Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter. Looking at the volume ...
The intervention being tested is PF-07899895, an experimental drug administered in ascending oral doses. The purpose is to assess its safety and pharmacokinetics compared to a placebo.
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has launched a Phase 1 clinical study titled ‘AN ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A Phase 1 / 2, ...
The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general ...
Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...
This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...
Pfizer's revenue has stabilized, and a recent drug pricing deal with the US government reduces political uncertainty. Find ...
“Obesity is a large and growing space with over 200 health conditions associated with it. The proposed acquisition of Metsera aligns with our focus on directing our investments to the most impactful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback